Tag: pharma
-
A Portfolio of Good Medicine
Dear Investors, Which Industry, other than IT Services, is India globally competitive? In which industry are Indian products of high quality and reasonable cost on a global scale? Which is the sector likely to do extremely well given today’s uncertainties? The answer is – the Indian Pharma Sector. JainMatrix Investments identified the pharma sector as…
-
Eris Lifesciences (IPO) is Strong on B2D
Date 15th June; IPO Open 16-20th June at Rs. 600-603 Valuations: P/E 34.3 times TTM, P/B 15.4 times Mid Cap: Rs. 8,300 crore Mkt cap Industry – Pharma sector Advice: Investors can BUY with a 2 year perspective Overview: Eris is an Ahmedabad based firm that develops, manufactures and sells branded pharma products from the…
-
Dr Lal Pathlabs IPO – Essential Services are an Essential Buy
Date 9th Dec 2015 Price range: Rs. 540-550 and application period: 8-10th Dec Industry: Pharma – Diagnostic services Mid Cap – Rs 4550 cr Mkt Cap Advice: Retail Investors can BUY with a 2-3 year perspective Summary Overview: DLP is provider of diagnostic and related healthcare tests and services. DLP’s Revenue, EBITDA and EPS have…
-
Alkem Labs IPO
Dear Reader, The IPO season in India continues with another bunch of offerings planned in December 2015. We have created a new IPO report on Alkem Labs. It is the first large pharma company IPO in over 10 years. Its got a lot going for it. At the same time, the criticism can be on the…
JainMatrix Investments 